Table 1.

Baseline characteristics of HB-HCC patients in two groups

	TACE-Iodine125 (n = 70)	TACE (n = 140)	p value
Age, year	51.1 ± 11.1 (28 ~ 80)	51.6 ± 10.8 (22 ~ 81)	0.748
Sex (M/F)	63/7	127/13	0.868
Type of PVTT (I+II/III)	41/29	82/58	1.000
APS (+/-)	20/50	39/101	0.914
Child-Pugh class (A/B)			0.558
A (A5, A6)	31 (15,16)	68 (35, 33)
B (B7, B8, B9)	39 (27,9,3)	72 (54,16,2)
ECOG (0/1 + 2)	41/29	79/61	0.767
Tumor size (cm), <7/≥7	39/31	83/57	0.621
Number of Tumor, <3/≥3	30/40	70/70	0.329
AFP level (ng/ml), <400/≥400	31/39	59/81	0.767
HBV DNA (IU/ml), <104/≥104	39/31	64/76	0.172
ALT, U/L	71.5 ± 32.6	71.2 ± 39.3	0.951
GGT, U/L	168.7 ± 54.0	157.4 ± 52.9	0.149
Albumin, g/L	36.1 ± 3.3	35.7 ± 2.9	0.353
TBIL, umol/L	15.9 ± 7.4	16.3 ± 7.6	0.683
Creatinine, umol/L	67.9 ± 14.7	65.3 ± 16.9	0.261
Platelet count, 109/L	118.6 ± 67.4	126.8 ± 55.1	0.345
Hemoglobin, g/L	124.0 ± 12.2	121.6 ± 14.8	0.235
White blood cell, 109/L	4.70 ± 1.05	4.61 ± 0.90	0.529